Evidence map›Paper›PMID 28871124›Full record

ArticleScientific reports2017

Cell Division Cycle 42 plays a Cell type-Specific role in Lung Tumorigenesis.

Chao Zheng, Yuetong Wang, Liu Yang, Shuhua Zhou, Yijun Gao, Fuming Li, Yan Feng, Zuoyun Wang, Lixing Zhan, Qin Yan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Chao ZhengState Key laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
Yuetong WangState Key laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
Liu YangState Key laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
Shuhua ZhouCAS center for Excellence in Molecular Cell Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
Yijun GaoState Key laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
Fuming LiState Key laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
Yan FengState Key laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
Zuoyun WangState Key laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
Lixing ZhanInstitute for Nutritional Sciences, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Qin YanDepartment of Pathology, Yale University School of Medicine, New Haven, CT, 06510, USA.ORCID 0000-0003-4077-453X
Xueliang ZhuState Key laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
Kwok-Kin WongDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, USA.
Zhengjun ChenState Key laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China. zjchen@sibcb.ac.cn.
Hongbin JiState Key laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China. hbji@sibcb.ac.cn.
Shanghai Institutes for Biological Sciences · CNChinese Academy of Sciences · CNDana-Farber Cancer Institute · USShanghaiTech University · CNYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell division cycle 42 (CDC42) plays important roles in polarity establishment and maintenance as well as cell cycle progression and cell division. Although disruption of cell polarity is a prerequisite in epithelial tumor initiation, the roles of CDC42 in tumorigenesis are still poorly understood. Here we find that Cdc42 deficiency inhibits the Kras

Indexed as

AnimalsBronchiolesCarcinoma, Non-Small-Cell Lungcdc42 GTP-Binding ProteinCell CommunicationCell LineCell LineageCell PolarityHumansLung NeoplasmsMiceNeoplasms, ExperimentalProto-Oncogene Proteins p21(ras)Pulmonary Surfactant-Associated Protein Acdc42 GTP-Binding ProteinCDC42 protein, humanKRAS protein, humanProto-Oncogene Proteins p21(ras)Pulmonary Surfactant-Associated Protein A

Identifiers

PMID28871124
PMCPMC5583260
OpenAlexW2752981216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.